Change in Ratings
downgraded at Deutsche Bank to a sell rating due to concerns that Medicare reimbursement rates will be lower on competitive bidding.
(ARO - Get Report)
downgraded at Citigroup from hold to sell, with a $24 price target. Inventory levels are building, especially women's, which could hurt near-term margins.
downgraded at Deutsche from hold to sell, with a $24 price target. Company facing increased competition, and Medicare reimbursement rates may be reset lower.
Medco Health Solutions
upgraded at Goldman to buy from neutral based on valuation. Believes shares are attractive following 23% decline from early January highs. Maintained $59 target price.
upgraded at Goldman to buy from neutral based on valuation. Cites stock is priced at a discount to peers despite delivering strong operating results last quarter. Sets $23 target price.
(SPLS - Get Report)
removed from Buy List at Goldman and now rates the stock neutral. Believes prospects are still bright but outlook is largely reflected in price. Maintained $25 target price.
(VSH - Get Report)
upgraded at Merrill from sell to neutral. Estimates cut, to reflect slower demand, but the company still has considerable opportunities to cut costs.
Stock Comments/EPS Changes
(GLW - Get Report)
2008 estimates raised at Deutsche Bank by 4 cents to $1.82 a share due to healthy global LCD demand and declining dollar.